Shandong Hengchen Biotechnology Co., Ltd.
Company OverviewFounded in April 2016 and based in Linyi, Shandong, Shandong Hengchen Biotechnology focuses on R&D, production and sales of Class I & II in vitro diagnostic reagents and instruments. Listed on Qilu Equity Exchange Center in 2020, it has been certified as a National High-Tech Enterprise and a Specialized & Innovative SME, driving industry development via technological innovation.II. Production FacilitiesThe company has 1,720 ㎡ of standardized production space, including a 600 ㎡ Class 10,000 clean workshop, a 500 ㎡ constant-temperature warehouse, a 200 ㎡ general workshop and an independent R&D & QC center. Supported by automated equipment and full-process ERP system, it realizes digital management, real-time data sharing and standardized production quality control.III. R&D TeamThe elite R&D team has nearly 20 professionals with high academic qualifications and senior technical titles. Through in-depth industry-university-research cooperation with local universities, the company has acquired dozens of patents and built a complete system for technical research, achievement transformation and clinical promotion.IV. Core AchievementsIts self-developed Group B Streptococcus chromogenic medium has obtained medical device registration approval. The automatic blood culture system project won a national science and technology progress award. As a domestic substitution benchmark product, it is the only NMPA-approved domestic device compatible with mainstream imported consumables, with performance reaching international advanced standards.V. Corporate MissionCommitted to precision medicine, Hengchen Biotechnology dedicates itself to developing efficient, affordable IVD solutions. It keeps making breakthroughs in microbial detection and molecular diagnosis, aiming to grow into a leading domestic IVD enterprise and deliver accessible high-quality medical services to more patients.
